Affiliation:
1. Kavli Institute for the Physics and Mathematics of the Universe (IPMU) (WPI), The University of Tokyo Institutes for Advanced Study (UTIAS) The University of Tokyo Kashiwa Chiba Japan
2. iMAGINE‐X Inc. Shibuya‐ku Tokyo Japan
3. Department of Physics The University of Tokyo Bunkyo‐ku Tokyo Japan
4. Division of Functional Imaging The National Cancer Center Japan Kashiwa Chiba Japan
Abstract
AbstractBackgroundThe recent emergence of targeted radionuclide therapy has increased the demand for imagers capable of visualizing pharmacokinetics in developing radiopharmaceuticals in the preclinical phase. Some radionuclides emit hard x‐rays and gamma‐rays below 100 keV, in which energy range the performance of conventional NaI scintillators is poor. Multipinhole collimators are also used for small animal imaging with a good spatial resolution but have a limited field of view (FOV).PurposeIn this study, a new imager with high sensitivity over a wide FOV in the low‐energy band (100 keV) was developed for the pharmacokinetic study.MethodsWe developed an x‐ray and gamma‐ray camera for high‐resolution spectroscopy, named “CdTe XG‐Cam,” equipped with a cadmium telluride semiconductor detector and a parallel‐hole collimator using a metal 3D printer. To evaluate the camera‐system performance, phantom measurements with single and dual nuclides (, , and were performed. The performance for in vivo imaging was evaluated using tumor‐bearing mice to which a nuclide ( or administered.ResultsWe simultaneously obtained information on and , which emit emission lines in the low‐energy band with peak energies close to each other (23–26 keV for and 27–31 keV for , and applied an analytical method based on spectral model fitting to determine the individual radioactivities accurately. In the small animal imaging, the distributions of the nuclide in tumors were accurately quantified and time‐activity curves in tumors are obtained.ConclusionsThe demonstrated capability of our system to perform in vivo imaging suggests that the camera can be used for applications of pharmacokinetics research.
Funder
Japan Society for the Promotion of Science